Anterior uveitis as a side effect of topical brimonidine

American Journal of Ophthalmology
D B BylesJ F Salmon

Abstract

To report anterior uveitis as a late side-effect of topical brimonidine tartrate 0.2% (Alphagan; Allergan Inc., Irvine, California). Four patients aged 79 to 91 (mean, 83) years, who developed acute anterior uveitis while using topical brimonidine for chronic glaucoma, were clinically evaluated for causes of uveitis. When the inflammation had completely cleared, topical brimonidine was recommenced in one eye only to determine causality. All four patients developed acute granulomatous anterior uveitis, which resolved rapidly on stopping brimonidine and receiving treatment with topical corticosteroids. The uveitis occurred 11 to 15 (mean, 13.8) months after commencement of brimonidine 0.2% twice daily. None of the patients had a previous history of uveitis, and no other identifiable cause of uveitis was found. In all patients, on rechallenge with brimonidine instilled twice daily to one eye, uveitis recurred within 3 weeks in that eye only. These findings suggest that brimonidine can cause anterior uveitis as a late side effect. The inflammation settles rapidly on stopping the medication and on using topical corticosteroids and recurs on rechallenge with brimonidine.

References

Sep 1, 1991·The British Journal of Ophthalmology·T Akingbehin, J R Villada
Dec 1, 1970·American Journal of Ophthalmology·T KrupinS M Podos
Aug 1, 1993·The British Journal of Ophthalmology·G R O'Connor
May 1, 1997·Experimental Eye Research·C D ThompsonS A Munk
Apr 29, 1998·Journal of the American Optometric Association·I B Gaddie, D W Bennett
Jun 23, 1998·Survey of Ophthalmology·R S MoorthyL M Jampol
Jan 7, 2000·Eye·S Kamalarajah, P B Johnston

❮ Previous
Next ❯

Citations

Mar 19, 2014·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Lisa A EngelArno Hueber
Jul 10, 2013·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Alfonso CasadoFrancisco J Muñoz-Negrete
Sep 3, 2002·Survey of Ophthalmology·Robert A SchumerAgneta K Mandahl
Dec 12, 2012·International Ophthalmology·María Alejandra CarrascoJorge Oscar Zárate
Dec 31, 2002·American Journal of Ophthalmology·Bushra MushtaqTim D Matthews
Mar 26, 2013·Journal of Ophthalmic Inflammation and Infection·Nikolas Js LondonEmmett T Cunningham
Apr 16, 2010·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·C M E DeuterM Zierhut
May 11, 2010·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·G GeerlingT Klink
Sep 25, 2015·Ocular Immunology and Inflammation·Jacqueline Beltz, Ehud Zamir
Oct 1, 2014·Expert Opinion on Pharmacotherapy·Sky K ChewIvan Goldberg
Apr 7, 2010·Expert Opinion on Drug Safety·Mamun Q RahmanDonald M I Montgomery
Oct 18, 2014·Expert Opinion on Drug Safety·Miguel Cordero-ComaTaygan Yilmaz
Mar 1, 2011·Expert Opinion on Emerging Drugs·Anne J Lee, Ivan Goldberg
Apr 29, 2011·Experimental Eye Research·Stella Arthur, Louis B Cantor
Sep 25, 2015·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Hye-Young ShinSu-Young Kim
Oct 28, 2003·The Journal of Dermatology·Punita Kumari SodhiJohn Ratan
Feb 22, 2007·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Ian F Gutteridge, Anthony J Hall
Aug 13, 2015·Medical Journal, Armed Forces India·Avadhesh Oli, D Joshi
Nov 12, 2015·BioMed Research International·Francisco J Muñoz-NegreteGema Rebolleda
Aug 14, 2001·Pharmacoepidemiology and Drug Safety
Sep 18, 2018·Current Opinion in Ophthalmology·Ramana S MoorthyEmmett T Cunningham
Jan 31, 2019·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Paul Y ChuaThorfinn Leslie
Feb 28, 2008·Journal of Glaucoma·Ethan V NguyenPeter McCluskey
May 7, 2005·Eye·J P Kersey, D C Broadway
Oct 9, 2013·Current Opinion in Ophthalmology·Ramana S MoorthyEmmett T Cunningham
Aug 3, 2019·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Hyung Bin HwangSu-Young Kim
Mar 3, 2015·International Ophthalmology Clinics·Amde Selassie ShiferaEric B Suhler
Apr 16, 2020·BMC Pharmacology & Toxicology·Ruiz Simonato AlonsoMarcelo Palis Ventura
Dec 19, 2020·BMC Ophthalmology·Susanne HopfVerena Prokosch-Willing
Jan 14, 2021·Survey of Ophthalmology·Maram E A Abdalla Elsayed, Igor Kozak
Feb 22, 2021·Vestnik oftalmologii·O D OstroumovaL K Moshetova
Jul 27, 2021·American Journal of Ophthalmology Case Reports·Aditya Mehta, Andrew Lewis
Jan 18, 2022·Clinical & Experimental Ophthalmology·Robert J Casson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.